Department of Biology and Bioinformatics Program, Boston University, Boston, Massachusetts, United States of America.
PLoS One. 2020 Dec 2;15(12):e0242665. doi: 10.1371/journal.pone.0242665. eCollection 2020.
Sex-specific transcription characterizes hundreds of genes in mouse liver, many implicated in sex-differential drug and lipid metabolism and disease susceptibility. While the regulation of liver sex differences by growth hormone-activated STAT5 is well established, little is known about autosomal genetic factors regulating the sex-specific liver transcriptome. Here we show, using genotyping and expression data from a large population of Diversity Outbred mice, that genetic factors work in tandem with growth hormone to control the individual variability of hundreds of sex-biased genes, including many long non-coding RNA genes. Significant associations between single nucleotide polymorphisms and sex-specific gene expression were identified as expression quantitative trait loci (eQTLs), many of which showed strong sex-dependent associations. Remarkably, autosomal genetic modifiers of sex-specific genes were found to account for more than 200 instances of gain or loss of sex-specificity across eight Diversity Outbred mouse founder strains. Sex-biased STAT5 binding sites and open chromatin regions with strain-specific variants were significantly enriched at eQTL regions regulating correspondingly sex-specific genes, supporting the proposed functional regulatory nature of the eQTL regions identified. Binding of the male-biased, growth hormone-regulated repressor BCL6 was most highly enriched at trans-eQTL regions controlling female-specific genes. Co-regulated gene clusters defined by overlapping eQTLs included sets of highly correlated genes from different chromosomes, further supporting trans-eQTL action. These findings elucidate how an unexpectedly large number of autosomal factors work in tandem with growth hormone signaling pathways to regulate the individual variability associated with sex differences in liver metabolism and disease.
性别特异性转录特征在数百个小鼠肝脏基因中存在,其中许多基因涉及性别差异的药物和脂质代谢以及疾病易感性。虽然生长激素激活的 STAT5 对肝脏性别差异的调节作用已得到充分证实,但对于调节性别特异性肝脏转录组的常染色体遗传因素知之甚少。在这里,我们使用来自大型多样性杂交小鼠群体的基因分型和表达数据表明,遗传因素与生长激素一起协同控制数百个性别偏向基因的个体变异性,包括许多长非编码 RNA 基因。单核苷酸多态性与性别特异性基因表达之间的显著关联被鉴定为表达数量性状基因座(eQTLs),其中许多表现出强烈的性别依赖性关联。值得注意的是,性别特异性基因的常染色体遗传修饰因子在八个多样性杂交小鼠原始株系中解释了超过 200 个性别特异性基因的获得或丧失的实例。性别特异性 STAT5 结合位点和具有株系特异性变异的开放染色质区域在调节相应性别特异性基因的 eQTL 区域中显著富集,支持所鉴定的 eQTL 区域的拟议功能调节性质。雄性偏倚的生长激素调节抑制剂 BCL6 的结合在控制雌性特异性基因的跨 eQTL 区域中最为丰富。通过重叠的 eQTL 定义的共调节基因簇包括来自不同染色体的高度相关基因的集合,进一步支持跨 eQTL 作用。这些发现阐明了大量常染色体因素如何与生长激素信号通路协同作用,以调节与肝脏代谢和疾病性别差异相关的个体变异性。